Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Baxter International Inc (BAX)

Baxter International Inc (BAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,710,518
  • Shares Outstanding, K 514,056
  • Annual Sales, $ 10,636 M
  • Annual Income, $ -649,000 K
  • EBIT $ 280 M
  • EBITDA $ 1,752 M
  • 60-Month Beta 0.61
  • Price/Sales 0.91
  • Price/Cash Flow 3.96
  • Price/Book 1.34

Options Overview Details

View History
  • Implied Volatility 42.31% (-3.61%)
  • Historical Volatility 53.76%
  • IV Percentile 74%
  • IV Rank 18.38%
  • IV High 129.94% on 11/04/25
  • IV Low 22.58% on 03/25/25
  • Expected Move (DTE 8) 0.78 (4.23%)
  • Put/Call Vol Ratio 2.25
  • Today's Volume 4,367
  • Volume Avg (30-Day) 6,455
  • Put/Call OI Ratio 1.63
  • Today's Open Interest 156,893
  • Open Int (30-Day) 165,286
  • Expected Range 17.70 to 19.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.53
  • Number of Estimates 8
  • High Estimate 0.55
  • Low Estimate 0.52
  • Prior Year 0.58
  • Growth Rate Est. (year over year) -8.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.40 +6.21%
on 11/20/25
19.19 -3.72%
on 12/01/25
+0.54 (+3.01%)
since 11/04/25
3-Month
17.40 +6.21%
on 11/20/25
24.63 -24.97%
on 09/10/25
-5.10 (-21.63%)
since 09/04/25
52-Week
17.40 +6.21%
on 11/20/25
37.74 -51.03%
on 03/10/25
-14.54 (-44.03%)
since 12/04/24

Most Recent Stories

More News
Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Baxter International Inc. (NYSE:BAX) (“ Baxter ” or the “ Company ”) today announced the consideration payable in connection with the previously announced cash tender...

BAX : 18.48 (-2.17%)
The Gross Law Firm Notifies Shareholders of Baxter International, Inc.(BAX) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK   , Dec. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX).

BAX : 18.48 (-2.17%)
Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Baxter International Inc. (NYSE:BAX) (“ Baxter ” or the “ Company ”) today announced the early tender results for the previously announced cash tender offers for the...

BAX : 18.48 (-2.17%)
2 Volatile Stocks with Exciting Potential and 1 We Question

2 Volatile Stocks with Exciting Potential and 1 We Question

SEZL : 66.72 (+3.54%)
BAX : 18.48 (-2.17%)
WT : 11.28 (+0.98%)
Contact Levi & Korsinsky by December 15, 2025 Deadline to Join Class Action Against Baxter International, Inc. (BAX)

NEW YORK , Dec. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ("Baxter International, Inc." or the "Company") (NYSE: BAX) of a class action securities...

BAX : 18.48 (-2.17%)
INVESTIGATION ALERT: Berger Montague PC Investigates Baxter International Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: BAX)

PHILADELPHIA , Dec. 1, 2025 /PRNewswire/ -- Berger Montague advises shareholders of Baxter International Inc. ("Baxter" or the "Company") (NYSE: BAX) about an investigation into Baxter's...

BAX : 18.48 (-2.17%)
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES , Dec. 1, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International...

BAX : 18.48 (-2.17%)
Faruqi & Faruqi Reminds Baxter Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - BAX

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options

BAX : 18.48 (-2.17%)
Baxter International, Inc. (BAX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , Nov. 26, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Baxter...

BAX : 18.48 (-2.17%)
BAX Deadline: BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit

NEW YORK , Nov. 25, 2025 /PRNewswire/ -- 

BAX : 18.48 (-2.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery,...

See More

Key Turning Points

3rd Resistance Point 19.43
2nd Resistance Point 19.18
1st Resistance Point 18.83
Last Price 18.48
1st Support Level 18.23
2nd Support Level 17.98
3rd Support Level 17.63

See More

52-Week High 37.74
Fibonacci 61.8% 29.97
Fibonacci 50% 27.57
Fibonacci 38.2% 25.17
Last Price 18.48
52-Week Low 17.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar